New York, NY, January 2, 2003 — Marcia A. Kean, a former partner of Feinstein Kean Healthcare, a unit of Ogilvy Public Relations Worldwide, has returned to the widely-regarded healthcare communications and business consulting firm in the position of chief executive officer.
She rejoins Feinstein Kean from Lexington-based Ardais Corporation, a privately-held clinical genomics firm, where she led the initial commercialization of that company’s drug discovery products and services.
“We asked Marcia back as part of Ogilvy’s strong commitment to Feinstein Kean Healthcare and its unique positioning as a senior strategic partner within the healthcare sector,” said Marcia Silverman, chief executive officer of Ogilvy Public Relations Worldwide. “Marcia returns to the firm as a proven leader with extensive biotech and pharmaceutical industry knowledge, a superb reputation with clients, and a strong track record for attracting, growing and retaining talented staff with diverse skill sets.”
Ogilvy PR Worldwide purchased Feinstein Kean in November 1999, attracted by Feinstein Kean’s unusual combination of pioneering biotechnology communications; its practice in pharmaceutical marketing that includes Top 10 Big Pharma companies; and its Kendall Strategies unit that develops commercialization strategies for early-stage health care products and companies.
“The biotech industry is maturing, with more companies at all stages of development having to confront a complex array of financing, public policy and commercial issues,” said Ms. Kean, who previously served as managing director of the FKH corporate communications practice for 12 years. “Feinstein Kean has the unique depth of experience and breadth of capabilities in the biotech and pharmaceutical arenas to address the strategic business and communications issues for companies from start-up through commercialization.”
Ms. Kean, whose career encompasses nearly 30 years of health care industry experience, has served in senior capacities in pharmaceutical and biotech firms, as well as in the non-profit health care sector. Before Feinstein Kean Healthcare, Ms. Kean served simultaneously as vice president, corporate communications of Damon Corporation and its subsidiary Damon Biotech, one of the first biotech companies in New England. Previously she held the position of Manager, Financial Relations for SmithKline Corporation. She is known as a pioneer of good practices in the biotech communications field, and is a prominent speaker and author on key communications and valuation issues facing senior management. She served on BIO’s Emerging Companies Section Governing Board from 1998 to 2001.
Ms. Kean holds an MBA in Finance from New York University and a BA from the University of California at Berkeley.
About Feinstein Kean Healthcare
Feinstein Kean Healthcare (FKH), a unit of Ogilvy Public Relations Worldwide, is a full-service communications and business consulting agency specializing in the healthcare industry — from concept to commercialization. The firm’s clients include global pharmaceutical, biotechnology, medical device, lifescience, genomics and healthcare information technology companies, associations, and other organizations in the healthcare economy. For more information, visit the Web site at www.fkhealth.com.
About Ogilvy Public Relations Worldwide
Ogilvy Public Relations Worldwide is a global marketing communications firm, with offices in more than 60 cities around the world. Entering its 24th year providing public relations solutions, Ogilvy Public Relations Worldwide has specialties in consumer marketing, corporate (B2B), health & medical, social marketing, technology, public affairs, government relations and entertainment. Through its subsidiary Feinstein Kean Healthcare, Ogilvy Public Relations Worldwide provides communication consulting to biotechnology companies. The Holmes Report has named Ogilvy Public Relations Worldwide 2003 International Agency of the Year; marking the fourth consecutive year the firm has been awarded “Agency of the Year.” Ogilvy Public Relations Worldwide is part of the WPP Group, the world’s largest marketing communications company (NASDAQ: WPPGY, www.wpp.com). For more information, visit our Web site at www.ogilvypr.com.